Assertio Therapeutics Q4 Earnings Preview
Mar. 08, 2022 11:32 AM ETAssertio Holdings, Inc. (ASRT)By: Urvi Shah, SA News Editor
- Assertio Therapeutics (NASDAQ:ASRT) is scheduled to announce Q4 earnings results on Wednesday, March 9th, before market open.
- The consensus EPS Estimate is $0.12 (+160.0% Y/Y) and the consensus Revenue Estimate is $30.77M (+2.0% Y/Y).
- Over the last 1 year, ASRT has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.